X

Albert David Ltd Q1FY24; 1050% rise in Profits

Albert David Ltd is engaged in manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export.

Financial Results:

Albert David Ltd reported Revenues for Q1FY24 of ₹92.00 Crores down from ₹93.00 Crore year on year, a fall of 1.08%.

Total Expenses for Q1FY24 of ₹81.00 Crores down from ₹83.00 Crores year on year, a fall of 2.41%.

Consolidated Net Profit of ₹23.00 Crores up 1050.0% from ₹2.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹41.16, up 1,236.36% from ₹3.08 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post